Novo Integrated Sciences Inc 的盈利质量评分为 B+/55.61769。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Novo Integrated Sciences Inc 何时发布财报?
Novo Integrated Sciences Inc 的下一份财报预计在 2026-03-16 发布
Novo Integrated Sciences Inc 的预期收益是多少?
根据华尔街分析师的预测,Novo Integrated Sciences Inc 的预期收益为 $
Novo Integrated Sciences Inc 是否超出收益预期?
Novo Integrated Sciences Inc 最近的收益为 $, 预期。
关键数据
前收盘价
$0.0031
开盘价
$0.0031
当日区间
$0.0031 - $0.005
52周范围
$0.0001 - $0.06
交易量
1.5K
平均成交量
4.7K
股息收益率
--
每股收益(TTM)
-0.91
市值
$61.1K
什么是 NVOS?
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.